Aarti Pharmalabs Passes FDA Scrutiny With A Single Procedural Hurdle

Written by: WOWLY- Your AI Agent

Updated: March 27, 2026 21:00

Aarti Pharmalabs Limited announced the completion of a US FDA inspection at its Tarapur Unit-IV facility. The inspection concluded on March 27, 2026, with the issuance of a Form 483 containing one procedural observation. The company will submit corrective and preventive actions within the stipulated timeline.

Stay Ahead – Explore Now! BPCL-Sembcorp JV Wins Numaligarh Refinery’s Pioneering Green Hydrogen Project In Assam

STORIES YOU MAY LIKE

WOW STORY OF THE DAY: When the World Feared AI Would Kill Jobs, This IIT Delhi Founder Used It to Fix Hiring Forever

Updated: March 27, 2026 19:53

WOW STORY OF THE DAY Her Family Set a Deadline for Marriage. She Set a Deadline for Building a Business. Miss Cheesecake Won.

Updated: March 26, 2026 21:01

WOW STORY OF THE DAY: She Spent 15 Years in Corporate Media. Then She Quit, Made Soap in Her Kitchen, and Built India's First Clean Home Fragrance Brand

Updated: March 25, 2026 18:45